ROLE OF TISSUE FACTOR IN DISSEMINATED INTRAVASCULAR COAGULATION

被引:60
作者
ASAKURA, H
KAMIKUBO, Y
GOTO, A
SHIRATORI, Y
YAMAZAKI, M
JOKAJI, H
SAITO, M
UOTANI, C
KUMABASHIRI, I
MORISHITA, E
AOSHIMA, K
NAKAMURA, S
MATSUDA, T
机构
[1] CHEMO SERO THERAPEUT RES INST,DIV BLOOD PROD,KUMAMOTO,JAPAN
[2] GIFU UNIV,SCH MED,GIFU 500,JAPAN
[3] KYOTO UNIV,PRIMATE RES INST,DEPT BIOCHEM,INUYAMA,AICHI 484,JAPAN
关键词
TISSUE FACTOR; DISSEMINATED INTRAVASCULAR COAGULATION; MULTIPLE ORGAN FAILURE;
D O I
10.1016/0049-3848(95)00170-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined plasma antigen levels of tissue factor (TF) in 95 cases of disseminated intravascular coagulation (DIC), to investigate the role of TF in DIC. A significant elevation of plasma antigen levels of TF was observed in cases of DIC associated with cancer. However, no such significant elevation was observed in cases of DIC associated with acute promyelocytic leukemia (APL), acute leukemia except APL, blastic crisis of chronic myelogenous leukemia, non-Hodgkin lymphoma (NHL), sepsis or fulminant hepatitis. No significant elevation of TF was observed in patients without DIC, except 4 cases of cancer who developed DIC thereafter. Plasma antigen levels of TF were higher in bath cases of DIC with renal failure and chronic renal failure without DIC than its levels in those without renal failure. Therefore,plasma antigen levels of TF in DIC patients with renal failure were considered to be carefully estimated. The levels of TF were decreased with the clinical improvement in some cases of DIC but were further increased or remained at high levels in patients who showed no improvement of DIC. Thus, plasma antigen levels of TF is an important marker to predict the development and/or prognosis of DIC, especially in patients with cancer.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 27 条
[1]  
AOKI N, 1988, ANN REPORT RES COMMI, P37
[2]   CHANGES IN PLASMA-LEVELS OF TISSUE-PLASMINOGEN ACTIVATOR INHIBITOR COMPLEX AND ACTIVE PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION [J].
ASAKURA, H ;
JOKAJI, H ;
SAITO, M ;
UOTANI, C ;
KUMABASHIRI, I ;
MORISHITA, E ;
YAMAZAKI, M ;
MATSUDA, T .
AMERICAN JOURNAL OF HEMATOLOGY, 1991, 36 (03) :176-183
[3]   PLASMA-LEVELS OF SOLUBLE THROMBOMODULIN INCREASE IN CASES OF DISSEMINATED INTRAVASCULAR COAGULATION WITH ORGAN FAILURE [J].
ASAKURA, H ;
JOKAJI, H ;
SAITO, M ;
UOTANI, C ;
KUMABASHIRI, I ;
MORISHITA, E ;
YAMAZAKI, M ;
MATSUDA, T .
AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (04) :281-287
[4]   LEVELS OF THROMBIN-ANTITHROMBIN-III COMPLEX IN PLASMA IN CASES OF ACUTE PROMYELOCYTIC LEUKEMIA [J].
ASAKURA, H ;
SAITO, M ;
ITO, K ;
JOKAJI, Y ;
UOTANI, C ;
KUMABASHIRI, I ;
MATSUDA, T .
THROMBOSIS RESEARCH, 1988, 50 (06) :895-899
[5]   CULTURED HUMAN-ENDOTHELIAL CELLS GENERATE TISSUE FACTOR IN RESPONSE TO ENDOTOXIN [J].
COLUCCI, M ;
BALCONI, G ;
LORENZET, R ;
PIETRA, A ;
LOCATI, D ;
DONATI, MB ;
SEMERARO, N .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (06) :1893-1896
[6]  
EDWARDS RL, 1981, J LAB CLIN MED, V98, P917
[7]  
Kobayashi N, 1983, Bibl Haematol, P265
[8]   DETERMINATION OF PLASMA TISSUE FACTOR ANTIGEN AND ITS CLINICAL-SIGNIFICANCE [J].
KOYAMA, T ;
NISHIDA, K ;
OHDAMA, S ;
SAWADA, M ;
MURAKAMI, N ;
HIROSAWA, S ;
KURIYAMA, R ;
MATSUZAWA, K ;
HASEGAWA, R ;
AOKI, N .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) :343-347
[9]  
LORENZET R, 1983, BLOOD, V62, P271
[10]  
MASON JW, 1971, THROMB DIATH HAEMO, V27, P325